Pfizer Sets Price of Covid Drug Paxlovid at $1,400 for Five-Day Course
TL;DR Summary
Pfizer will price its COVID-19 drug, Paxlovid, at $1,390 for a five-day course when commercial sales begin, more than double what the U.S. government has paid, raising concerns about patient access.
- Pfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day Course - WSJ The Wall Street Journal
- COVID antiviral Paxlovid to see price increase following 400% vaccine hike Ars Technica
- Need for Paxlovid in poor countries far outstripped supplies in 2022, report says University of Minnesota Twin Cities
- Pfizer to price Covid drug Paxlovid at $1,390 per course CNBC
- Pfizer to price COVID treatment Paxlovid at $1390 per course Reuters
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
67%
95 → 31 words
Want the full story? Read the original article
Read on The Wall Street Journal